Is It Safe to Take Glutathione While Pregnant?

Glutathione is the body’s most abundant internally produced antioxidant, and during pregnancy it plays a heightened role in protecting both the mother and the developing fetus from oxidative damage. Lower glutathione levels have been linked to several serious pregnancy complications, which has driven interest in supplementation. But the relationship between glutathione and pregnancy is not as simple as “more is better,” and the science around taking glutathione supplements during pregnancy is thinner than the marketing suggests. Most of the research connects glutathione to pregnancy outcomes through observational studies and animal models, not through well-designed human trials showing that supplementation improves those outcomes.

What Glutathione Does During Pregnancy

Every cell in your body makes glutathione from three amino acids. It neutralizes reactive oxygen species, recycles other antioxidants like vitamins C and E, and helps the liver process drugs and environmental toxins. During pregnancy, the demand for this work increases substantially. The placenta is metabolically active tissue that generates its own oxidative byproducts, and the growing fetus depends on antioxidant protection as its organs develop.

Despite the increased demand, glutathione levels in healthy pregnancies stay relatively stable across all three trimesters. A study measuring plasma glutathione peroxidase found mean levels of roughly 84, 81, and 90 ng/mL across the first, second, and third trimesters respectively, with no meaningful correlation between the enzyme’s concentration and gestational age.¹ In other words, a healthy pregnant body appears to keep up with the extra oxidative load without its glutathione system falling behind. The problems begin when something disrupts that balance.

Low Glutathione and Pregnancy Complications

A consistent pattern emerges across the research on complicated pregnancies: when things go wrong, glutathione levels tend to be lower than normal. This has been documented in preeclampsia, gestational diabetes, and fetal growth restriction, though the direction of causation remains an open question in most cases.

In preeclampsia, both total glutathione and reduced glutathione levels are significantly lower than in normal pregnancies, as measured in early pregnancy samples.² A separate analysis found that whole blood glutathione was also lower in pregnancies complicated by preeclampsia or HELLP syndrome, with median total glutathione of 647 micromol/L compared to 750 micromol/L in women with normal blood pressure.³ Those numbers overlap enough that glutathione alone is not useful as a diagnostic test, but the trend is clear.

In gestational diabetes, glutathione peroxidase activity is lower, particularly during the first trimester. A longitudinal study following women through all three trimesters found that this enzyme activity was consistently depressed in women who developed gestational diabetes, and that it tracked inversely with markers of oxidative damage and blood sugar control.⁴ The worse the blood sugar, the lower the antioxidant activity and the higher the oxidative stress markers.

Fetal growth restriction shows a similar picture. Neonates born with intrauterine growth restriction have significantly lower antioxidant enzyme activities and antioxidant levels in their cord blood, alongside elevated markers of lipid and DNA damage.⁵ The same pattern appears on the placental side: glutathione levels and the activity of glutathione-related enzymes are measurably lower in the placentas of growth-restricted pregnancies, along with reduced expression of the genes that code for those enzymes.⁶ A scoping review of cord blood biomarkers confirmed that glutathione was among the oxidative stress markers most consistently associated with suspected growth restriction.⁷

The critical caveat with all of this data is that lower glutathione may be a consequence of the disease process rather than its cause. Preeclampsia, for instance, involves widespread inflammation and endothelial damage that consume antioxidants. The low glutathione readings might reflect the body’s defense being used up, not a shortage that triggered the condition in the first place. This distinction matters enormously for the question of whether supplementation would help.

Why Oral Glutathione Supplements Are Unlikely to Help

If low glutathione is linked to bad outcomes, it seems logical to take more of it. The trouble is that glutathione taken by mouth barely survives digestion. Enzymes in the gut break it down into its component amino acids before much of it reaches the bloodstream intact. Research on oral bioavailability has found that native glutathione has an oral bioavailability of only about 0.7%, meaning less than one percent of what you swallow arrives as functional glutathione in your blood.⁸ Novel chemical analogues have boosted this to around 11% in experimental settings, but those are not commercially available supplements.

This does not mean oral glutathione supplements do nothing at all. The amino acids released during digestion can be reassembled into glutathione by your cells. But the effect is indirect and modest, and it raises the question of whether you would be better off just eating foods rich in those same amino acids. Sulfur-containing foods like cruciferous vegetables, garlic, onions, and protein sources naturally provide the building blocks your body uses to make glutathione on its own.

The broader track record of antioxidant supplementation during pregnancy has been disappointing. Large-scale randomized trials of antioxidant supplements in pregnant women have failed to demonstrate positive effects on preeclampsia or other outcomes, despite the compelling observational data linking oxidative stress to those conditions.⁹ The gap between “low levels are associated with complications” and “adding more prevents complications” has proven stubbornly wide.

N-Acetylcysteine as a Glutathione Precursor

Rather than supplementing glutathione directly, some researchers have focused on N-acetylcysteine (NAC), a compound that the body readily converts into cysteine, the rate-limiting amino acid in glutathione production. NAC has a long clinical track record as the standard antidote for acetaminophen (paracetamol) poisoning, including in pregnant women, and it crosses the placenta at therapeutic concentrations.¹⁰ In cases of acetaminophen overdose during pregnancy, NAC effectively replenishes the glutathione that the drug depletes, and studies have found cord blood concentrations of NAC consistent with therapeutic adult levels, with no adverse effects seen in viable infants.¹¹

Animal research has explored NAC as a preventive measure rather than an emergency treatment. In a mouse model of gestational diabetes, oral NAC improved blood sugar tolerance, reduced markers of oxidative damage, and activated protective antioxidant pathways in the liver. It also restored litter sizes and reduced the abnormally high birth weights associated with diabetic pregnancies.¹² In pigs, NAC supplementation during late pregnancy increased glutathione peroxidase activity in the placenta, lowered oxidative stress markers, and reduced inflammatory signaling, though it did not improve litter outcomes like the number or weight of piglets.¹³

These findings are encouraging at the biological level but cannot be directly applied to pregnant women deciding what supplements to take. Animal models are starting points, not prescriptions. NAC is used in human pregnancy under medical supervision for specific emergencies, but routine supplementation to boost glutathione has not been validated in large human trials. If you are interested in NAC, it is a conversation to have with your OB, not a decision to make based on supplement marketing.

Injectable Glutathione and Known Risks

Intravenous and injectable glutathione products are marketed in some parts of the world for skin lightening and general “detox” purposes, and some pregnant women encounter them through cosmetic clinics. The safety profile of these products during pregnancy is essentially uncharted, and what little data exists is concerning.

A case analysis presented at a gastroenterology conference documented severe allergic reactions in women during their third trimester who received reduced glutathione by injection, concluding that the injected form may lead to serious allergic events in late pregnancy.¹⁴ Beyond pregnancy-specific risks, the U.S. FDA has flagged injectable skin-lightening products as potentially unsafe, and the Philippines FDA has warned about toxic effects on the liver, kidneys, and nervous system from injectable glutathione, particularly when administered by non-medical professionals or in unsterile environments.¹⁵ The risks of contamination, endotoxins, and pathogen transmission that affect any unregulated injectable product are amplified during pregnancy, when the immune system is naturally altered and the stakes include a developing fetus.

The bottom line on injectable glutathione during pregnancy is straightforward: there is no evidence it provides any benefit, and there are documented reasons to think it could cause harm.

Environmental Exposures That Drain Glutathione

While supplementation gets the most attention, the other side of the equation matters too: what depletes glutathione during pregnancy? Exposure to heavy metals like lead and cadmium has been shown to decrease reduced glutathione in the blood, while simultaneously increasing lipid peroxidation, a type of oxidative damage to cell membranes.¹⁶ The researchers suggested that metal exposure during pregnancy could worsen complications by depleting the very antioxidant reserves needed to keep oxidative stress in check.

This is worth knowing because reducing exposure to environmental toxins may be more impactful than adding supplements. Avoiding lead paint, checking well water, minimizing exposure to cigarette smoke (including secondhand), and being cautious with certain cosmetics and imported foods are practical steps that protect glutathione reserves. The same logic applies to excessive acetaminophen use. While standard doses are considered safe in pregnancy, overuse depletes glutathione through a well-understood metabolic pathway, and malnourished women are especially vulnerable to this effect.¹⁷

Genetic Variations in Glutathione Processing

Not every pregnant woman processes glutathione the same way. The glutathione S-transferase (GST) family of enzymes helps the body use glutathione to neutralize toxins, and some people carry “null” versions of these genes, meaning their bodies make little or none of a particular GST enzyme. These genetic variations have been studied in relation to pregnancy loss and fetal outcomes.

Research on recurrent pregnancy loss has found that women carrying a null version of the GSTT1 gene, or combined GSTT1/GSTM1 null genotypes, are significantly overrepresented among those who experience repeated miscarriages.¹⁸ A separate study in an Indian population and accompanying meta-analysis found that the GSTT1 null genotype carried roughly four-fold higher odds of early pregnancy loss.¹⁹ However, these associations vary across populations, and neither study alone is definitive for all groups.

The fetus’s own genetics matter as well. A study of fetal copy number variants found that babies carrying a functional copy of the GSTM1 gene had about a third lower odds of being born prematurely, while a different variant in GSTT2B was linked to a modestly increased risk of being born small for gestational age.²⁰ These findings suggest that the baby’s ability to handle oxidative stress independently from the mother’s system plays a role in pregnancy outcomes.

Genetic testing for GST variants is not part of standard prenatal care, and knowing your genotype would not currently change clinical management. But this research helps explain why some women seem more vulnerable to oxidative stress-related complications than others, even when their diets and exposures are similar.

Glutathione’s Role Before Conception

The connection between glutathione and reproduction begins before pregnancy. The fluid surrounding the developing egg in the ovary contains glutathione and its related enzymes, and their levels appear to influence egg quality. A cross-sectional study of women undergoing IVF found that higher levels of glutathione peroxidase and glutathione reductase activity in follicular fluid were associated with better oocyte quality, with an increasing trend that correlated with more favorable embryo outcomes.²¹ Women with polycystic ovary syndrome, who often have disrupted antioxidant balance, showed particularly strong correlations between follicular glutathione activity and egg maturation.

This does not mean taking glutathione supplements before IVF will produce better eggs. As with most of the observational data in this area, the correlation might simply reflect that healthier follicular environments produce both more glutathione and better eggs, rather than glutathione itself being the driver. Still, the finding reinforces the idea that antioxidant status at the time of conception sets a baseline for what follows.

Maternal Diet and Fetal Glutathione Programming

An intriguing line of animal research suggests that what a mother eats during pregnancy can change how her offspring produce glutathione long after birth. In a mouse study, a high-fat diet during pregnancy caused chemical modifications to the DNA regions that control glutathione synthesis genes in the offspring, effectively dialing down their ability to make glutathione. Supplementing the mother’s diet with the amino acid serine during pregnancy prevented these changes, keeping the glutathione-related genes active and reducing oxidative stress in the pups.²²

This kind of epigenetic programming is one of the more fascinating areas of developmental biology. The takeaway is not that pregnant women should rush to buy serine supplements. It is that maternal nutrition can shape the offspring’s own antioxidant capacity in ways that outlast the pregnancy itself. The quality of the mother’s overall diet, rather than any single supplement, likely matters most for establishing healthy glutathione biology in the next generation.

Glutathione in Breast Milk

Newborns have limited capacity to synthesize their own glutathione, which makes breast milk an important external source. Analysis of human breast milk from healthy mothers found average total glutathione content of about 192 micromol/L. Notably, early milk fed to infants during the first four weeks of life had significantly higher glutathione concentrations, averaging around 253 micromol/L, compared to about 164 micromol/L in mature milk from mothers with older infants.²³ The same study raised concerns that storing breast milk could reduce its glutathione content, potentially weakening the antioxidant protection it provides. For mothers who pump and store milk, this is a practical consideration: fresh milk delivers more antioxidant value than stored milk, particularly during those first critical weeks when the baby’s own production systems are still ramping up.

The higher glutathione content of early milk aligns with a broader pattern in breast milk composition, where colostrum and early milk are especially rich in immune and protective factors that taper off as the infant’s own systems mature. It is another reason breastfeeding advocates emphasize the value of even brief periods of nursing in the first days and weeks postpartum, when the biological payoff per feeding is highest.